Complete Genomics

life sciences company that has developed and commercialized a DNA sequencing platform for human genome sequencing and analysis

Complete Genomics (CG) is an American biotech company. They wikt:analyse DNA as a commercial service. CG has created commercial a DNA sequencing platform for human genome. The company was founded in 2006. It is based in Mountain View, California

In March 2013, Complete Genomics was bought by BGI-Shenzhen. It is the world’s largest genomics services company. BGI is a 4,000-person company in Shenzhen, Guangdong, China. It provides sequencing and bioinformatics services for commercial science, medical, agricultural, and environmental uses.[1]

In February 2009, Complete Genomics said that it had sequenced its first human genome. They gave the results to the National Center for Biotechnology Information database. In November 2009, CG published sequence data for three human genomes in the journal Science.[2] By the end of 2009, CG had sequenced 50 human genomes. By 2015, the company has sequenced more than 20,000 genomes.

In 2014, CC worked with Radboud University (The Netherlands), Maastricht University Medical Centre (The Netherlands) and Central South University (China) to identify a major causes of intellectual disability.[3]

References change

  1. Specter, Michael (6 January 2014). "The Gene Factory". The New Yorker. Retrieved 28 October 2014.
  2. Drmanac R (2009). "Human genome sequencing using unchained base reads on self-assembling DNA nanoarrays". Science. 327 (5961): 78–81. Bibcode:2010Sci...327...78D. doi:10.1126/science.1181498. PMID 19892942. S2CID 17309571.
  3. Gilissen C; et al. (2014). "Genome sequencing identifies major causes of severe intellectual disability" (PDF). Nature. 511 (7509): 344–347. doi:10.1038/nature13394. PMID 24896178. S2CID 205238886.